JACK vs VRTX · rev $1.47B vs P/E 30, rev $12.00B
Jacktel AS (JACK) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Jacktel AS (JACK) is a restaurants company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported JACK revenue for 2025-09-28 was $1.47B. Net income was -$80.7M. Revenue was down 6.7% from 2024-09-29 to 2025-09-28. JACK currently screens at market cap $215.9M.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
JACK currently screens at market cap $215.9M. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the JACK and VRTX stock pages for the full models.
Not investment advice.